Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

NGNE

Neurogene (NGNE)

Neurogene Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NGNE
DatumZeitQuelleÜberschriftSymbolFirma
01/07/202413h30Business WireNeurogene Announces Addition to Russell 3000® IndexNASDAQ:NGNENeurogene Inc
18/06/202415h26Business WireNeurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett SyndromeNASDAQ:NGNENeurogene Inc
05/06/202413h30Business WireNeurogene to Participate in Upcoming ConferencesNASDAQ:NGNENeurogene Inc
03/06/202413h30Business WireNeurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot ProgramNASDAQ:NGNENeurogene Inc
10/05/202413h30Business WireNeurogene Reports First Quarter 2024 Financial Results and Highlights Recent UpdatesNASDAQ:NGNENeurogene Inc
07/05/202412h19Business WireNeurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual MeetingNASDAQ:NGNENeurogene Inc
22/04/202422h36Business WireNeurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT MeetingNASDAQ:NGNENeurogene Inc
18/03/202421h14Business WireNeurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent UpdatesNASDAQ:NGNENeurogene Inc
04/03/202413h30Business WireNeurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical TrialNASDAQ:NGNENeurogene Inc
29/02/202413h30Business WireNeurogene to Participate in Upcoming Investor ConferencesNASDAQ:NGNENeurogene Inc
16/01/202413h00Business WireNeurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical OfficerNASDAQ:NGNENeurogene Inc
05/01/202413h00Business WireNeurogene Announces Business Update and 2024 OutlookNASDAQ:NGNENeurogene Inc
 Showing the most relevant articles for your search:NASDAQ:NGNE